Improving The Quality of Care for Persons With Advanced Epithelial Ovarian Cancer

Click to increase image sizeClick to decrease image size

Additional information

Notes on contributors

Premal H. Thaker

Premal H. Thaker, MD, MS, is professor at Washington University, Siteman Cancer Center, Saint Louis, Mo. Matthew P. Smeltzer, PhD, is associate professor in the Division of Epidemiology, Biostatistics, and Environmental Health School of Public Health, University of Memphis, Memphis, Tenn. Monique Dawkins, EdD, is assistant director, education, and Leigh M. Boehmer, PharmD, BCOP, is medical director at the Association of Community Cancer Centers, Rockville, Md. Leigha Senter-Jamieson, MS, is associate professor at The Ohio State University, James Cancer Hospital, Comprehensive Cancer Center, Columbus, Ohio. Stephanie V. Blank, MD, is professor and division director of gynecologic oncology, and Mollie Finkel, RN, MSN, is clinal program manager at the Blavatnik Family—Chelsea Medical Center, The Mount Sinai Hospital, New York, N.Y. Destin Black, MD, is director of gynecologic oncology at Willis-Knighton Cancer Center and Louisiana State University Health Shreveport, La. Anna Yemelyanova, MD, is professor of pathology at the Department of Pathology & Laboratory Medicine, Weill Cornell Medicine, New York, N.Y. Sarah Temkin, MD, is a gynecologic oncologist in Washington, D.C.

Matthew P. Smeltzer

Premal H. Thaker, MD, MS, is professor at Washington University, Siteman Cancer Center, Saint Louis, Mo. Matthew P. Smeltzer, PhD, is associate professor in the Division of Epidemiology, Biostatistics, and Environmental Health School of Public Health, University of Memphis, Memphis, Tenn. Monique Dawkins, EdD, is assistant director, education, and Leigh M. Boehmer, PharmD, BCOP, is medical director at the Association of Community Cancer Centers, Rockville, Md. Leigha Senter-Jamieson, MS, is associate professor at The Ohio State University, James Cancer Hospital, Comprehensive Cancer Center, Columbus, Ohio. Stephanie V. Blank, MD, is professor and division director of gynecologic oncology, and Mollie Finkel, RN, MSN, is clinal program manager at the Blavatnik Family—Chelsea Medical Center, The Mount Sinai Hospital, New York, N.Y. Destin Black, MD, is director of gynecologic oncology at Willis-Knighton Cancer Center and Louisiana State University Health Shreveport, La. Anna Yemelyanova, MD, is professor of pathology at the Department of Pathology & Laboratory Medicine, Weill Cornell Medicine, New York, N.Y. Sarah Temkin, MD, is a gynecologic oncologist in Washington, D.C.

Monique Dawkins

Premal H. Thaker, MD, MS, is professor at Washington University, Siteman Cancer Center, Saint Louis, Mo. Matthew P. Smeltzer, PhD, is associate professor in the Division of Epidemiology, Biostatistics, and Environmental Health School of Public Health, University of Memphis, Memphis, Tenn. Monique Dawkins, EdD, is assistant director, education, and Leigh M. Boehmer, PharmD, BCOP, is medical director at the Association of Community Cancer Centers, Rockville, Md. Leigha Senter-Jamieson, MS, is associate professor at The Ohio State University, James Cancer Hospital, Comprehensive Cancer Center, Columbus, Ohio. Stephanie V. Blank, MD, is professor and division director of gynecologic oncology, and Mollie Finkel, RN, MSN, is clinal program manager at the Blavatnik Family—Chelsea Medical Center, The Mount Sinai Hospital, New York, N.Y. Destin Black, MD, is director of gynecologic oncology at Willis-Knighton Cancer Center and Louisiana State University Health Shreveport, La. Anna Yemelyanova, MD, is professor of pathology at the Department of Pathology & Laboratory Medicine, Weill Cornell Medicine, New York, N.Y. Sarah Temkin, MD, is a gynecologic oncologist in Washington, D.C.

Leigha Senter-Jamieson

Premal H. Thaker, MD, MS, is professor at Washington University, Siteman Cancer Center, Saint Louis, Mo. Matthew P. Smeltzer, PhD, is associate professor in the Division of Epidemiology, Biostatistics, and Environmental Health School of Public Health, University of Memphis, Memphis, Tenn. Monique Dawkins, EdD, is assistant director, education, and Leigh M. Boehmer, PharmD, BCOP, is medical director at the Association of Community Cancer Centers, Rockville, Md. Leigha Senter-Jamieson, MS, is associate professor at The Ohio State University, James Cancer Hospital, Comprehensive Cancer Center, Columbus, Ohio. Stephanie V. Blank, MD, is professor and division director of gynecologic oncology, and Mollie Finkel, RN, MSN, is clinal program manager at the Blavatnik Family—Chelsea Medical Center, The Mount Sinai Hospital, New York, N.Y. Destin Black, MD, is director of gynecologic oncology at Willis-Knighton Cancer Center and Louisiana State University Health Shreveport, La. Anna Yemelyanova, MD, is professor of pathology at the Department of Pathology & Laboratory Medicine, Weill Cornell Medicine, New York, N.Y. Sarah Temkin, MD, is a gynecologic oncologist in Washington, D.C.

Stephanie V. Blank

Premal H. Thaker, MD, MS, is professor at Washington University, Siteman Cancer Center, Saint Louis, Mo. Matthew P. Smeltzer, PhD, is associate professor in the Division of Epidemiology, Biostatistics, and Environmental Health School of Public Health, University of Memphis, Memphis, Tenn. Monique Dawkins, EdD, is assistant director, education, and Leigh M. Boehmer, PharmD, BCOP, is medical director at the Association of Community Cancer Centers, Rockville, Md. Leigha Senter-Jamieson, MS, is associate professor at The Ohio State University, James Cancer Hospital, Comprehensive Cancer Center, Columbus, Ohio. Stephanie V. Blank, MD, is professor and division director of gynecologic oncology, and Mollie Finkel, RN, MSN, is clinal program manager at the Blavatnik Family—Chelsea Medical Center, The Mount Sinai Hospital, New York, N.Y. Destin Black, MD, is director of gynecologic oncology at Willis-Knighton Cancer Center and Louisiana State University Health Shreveport, La. Anna Yemelyanova, MD, is professor of pathology at the Department of Pathology & Laboratory Medicine, Weill Cornell Medicine, New York, N.Y. Sarah Temkin, MD, is a gynecologic oncologist in Washington, D.C.

Destin Black

Premal H. Thaker, MD, MS, is professor at Washington University, Siteman Cancer Center, Saint Louis, Mo. Matthew P. Smeltzer, PhD, is associate professor in the Division of Epidemiology, Biostatistics, and Environmental Health School of Public Health, University of Memphis, Memphis, Tenn. Monique Dawkins, EdD, is assistant director, education, and Leigh M. Boehmer, PharmD, BCOP, is medical director at the Association of Community Cancer Centers, Rockville, Md. Leigha Senter-Jamieson, MS, is associate professor at The Ohio State University, James Cancer Hospital, Comprehensive Cancer Center, Columbus, Ohio. Stephanie V. Blank, MD, is professor and division director of gynecologic oncology, and Mollie Finkel, RN, MSN, is clinal program manager at the Blavatnik Family—Chelsea Medical Center, The Mount Sinai Hospital, New York, N.Y. Destin Black, MD, is director of gynecologic oncology at Willis-Knighton Cancer Center and Louisiana State University Health Shreveport, La. Anna Yemelyanova, MD, is professor of pathology at the Department of Pathology & Laboratory Medicine, Weill Cornell Medicine, New York, N.Y. Sarah Temkin, MD, is a gynecologic oncologist in Washington, D.C.

Mollie Finkel

Premal H. Thaker, MD, MS, is professor at Washington University, Siteman Cancer Center, Saint Louis, Mo. Matthew P. Smeltzer, PhD, is associate professor in the Division of Epidemiology, Biostatistics, and Environmental Health School of Public Health, University of Memphis, Memphis, Tenn. Monique Dawkins, EdD, is assistant director, education, and Leigh M. Boehmer, PharmD, BCOP, is medical director at the Association of Community Cancer Centers, Rockville, Md. Leigha Senter-Jamieson, MS, is associate professor at The Ohio State University, James Cancer Hospital, Comprehensive Cancer Center, Columbus, Ohio. Stephanie V. Blank, MD, is professor and division director of gynecologic oncology, and Mollie Finkel, RN, MSN, is clinal program manager at the Blavatnik Family—Chelsea Medical Center, The Mount Sinai Hospital, New York, N.Y. Destin Black, MD, is director of gynecologic oncology at Willis-Knighton Cancer Center and Louisiana State University Health Shreveport, La. Anna Yemelyanova, MD, is professor of pathology at the Department of Pathology & Laboratory Medicine, Weill Cornell Medicine, New York, N.Y. Sarah Temkin, MD, is a gynecologic oncologist in Washington, D.C.

Anna Yemelyanova

Premal H. Thaker, MD, MS, is professor at Washington University, Siteman Cancer Center, Saint Louis, Mo. Matthew P. Smeltzer, PhD, is associate professor in the Division of Epidemiology, Biostatistics, and Environmental Health School of Public Health, University of Memphis, Memphis, Tenn. Monique Dawkins, EdD, is assistant director, education, and Leigh M. Boehmer, PharmD, BCOP, is medical director at the Association of Community Cancer Centers, Rockville, Md. Leigha Senter-Jamieson, MS, is associate professor at The Ohio State University, James Cancer Hospital, Comprehensive Cancer Center, Columbus, Ohio. Stephanie V. Blank, MD, is professor and division director of gynecologic oncology, and Mollie Finkel, RN, MSN, is clinal program manager at the Blavatnik Family—Chelsea Medical Center, The Mount Sinai Hospital, New York, N.Y. Destin Black, MD, is director of gynecologic oncology at Willis-Knighton Cancer Center and Louisiana State University Health Shreveport, La. Anna Yemelyanova, MD, is professor of pathology at the Department of Pathology & Laboratory Medicine, Weill Cornell Medicine, New York, N.Y. Sarah Temkin, MD, is a gynecologic oncologist in Washington, D.C.

Leigh M. Boehmer

Premal H. Thaker, MD, MS, is professor at Washington University, Siteman Cancer Center, Saint Louis, Mo. Matthew P. Smeltzer, PhD, is associate professor in the Division of Epidemiology, Biostatistics, and Environmental Health School of Public Health, University of Memphis, Memphis, Tenn. Monique Dawkins, EdD, is assistant director, education, and Leigh M. Boehmer, PharmD, BCOP, is medical director at the Association of Community Cancer Centers, Rockville, Md. Leigha Senter-Jamieson, MS, is associate professor at The Ohio State University, James Cancer Hospital, Comprehensive Cancer Center, Columbus, Ohio. Stephanie V. Blank, MD, is professor and division director of gynecologic oncology, and Mollie Finkel, RN, MSN, is clinal program manager at the Blavatnik Family—Chelsea Medical Center, The Mount Sinai Hospital, New York, N.Y. Destin Black, MD, is director of gynecologic oncology at Willis-Knighton Cancer Center and Louisiana State University Health Shreveport, La. Anna Yemelyanova, MD, is professor of pathology at the Department of Pathology & Laboratory Medicine, Weill Cornell Medicine, New York, N.Y. Sarah Temkin, MD, is a gynecologic oncologist in Washington, D.C.

Sarah Temkin

Premal H. Thaker, MD, MS, is professor at Washington University, Siteman Cancer Center, Saint Louis, Mo. Matthew P. Smeltzer, PhD, is associate professor in the Division of Epidemiology, Biostatistics, and Environmental Health School of Public Health, University of Memphis, Memphis, Tenn. Monique Dawkins, EdD, is assistant director, education, and Leigh M. Boehmer, PharmD, BCOP, is medical director at the Association of Community Cancer Centers, Rockville, Md. Leigha Senter-Jamieson, MS, is associate professor at The Ohio State University, James Cancer Hospital, Comprehensive Cancer Center, Columbus, Ohio. Stephanie V. Blank, MD, is professor and division director of gynecologic oncology, and Mollie Finkel, RN, MSN, is clinal program manager at the Blavatnik Family—Chelsea Medical Center, The Mount Sinai Hospital, New York, N.Y. Destin Black, MD, is director of gynecologic oncology at Willis-Knighton Cancer Center and Louisiana State University Health Shreveport, La. Anna Yemelyanova, MD, is professor of pathology at the Department of Pathology & Laboratory Medicine, Weill Cornell Medicine, New York, N.Y. Sarah Temkin, MD, is a gynecologic oncologist in Washington, D.C.